Duration of acceptable delay between the time of diagnosis and treatment of melanoma, cutaneous squamous cell carcinoma and basal cell carcinoma
Corresponding Author
M. Alam
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Department of Otolaryngology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
*Correspondence: M. Alam. E-mail: [email protected]
Search for more papers by this authorJ.R. Etzkorn
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Search for more papers by this authorJ.G. Albertini
The Skin Surgery Center, Winston-Salem, NC, USA
Wake Forest Department of Plastic and Reconstructive Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA
Search for more papers by this authorJ.S. Bordeaux
Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
Search for more papers by this authorM.L. Council
Division of Dermatology, Center for Dermatologic and Cosmetic Surgery, Washington University in Saint Louis, Saint Louis, MO, USA
Search for more papers by this authorI.A. Maher
Department of Dermatology, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorK.S. Nehal
Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Search for more papers by this authorD.G. Brodland
Zitelli & Brodland, P.C. Skin Cancer Center, Pittsburgh, PA, USA
Departments of Dermatology, Otolaryngology, and Plastic Surgery, University of Pittsburgh, Pittsburgh, PA, USA
Search for more papers by this authorA.F. Haas
Sutter Health/Department of Dermatology, University of California-Davis, Sacramento, CA, USA
Search for more papers by this authorB.Y. Kang
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Search for more papers by this authorS.A. Ibrahim
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Search for more papers by this authorR.E. Christensen
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Search for more papers by this authorE. Poon
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Search for more papers by this authorB. Worley
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Florida Dermatology and Skin Cancer Centers, Lake Wales, FL, USA
Search for more papers by this authorCorresponding Author
M. Alam
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Department of Otolaryngology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
*Correspondence: M. Alam. E-mail: [email protected]
Search for more papers by this authorJ.R. Etzkorn
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Search for more papers by this authorJ.G. Albertini
The Skin Surgery Center, Winston-Salem, NC, USA
Wake Forest Department of Plastic and Reconstructive Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA
Search for more papers by this authorJ.S. Bordeaux
Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
Search for more papers by this authorM.L. Council
Division of Dermatology, Center for Dermatologic and Cosmetic Surgery, Washington University in Saint Louis, Saint Louis, MO, USA
Search for more papers by this authorI.A. Maher
Department of Dermatology, University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorK.S. Nehal
Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Search for more papers by this authorD.G. Brodland
Zitelli & Brodland, P.C. Skin Cancer Center, Pittsburgh, PA, USA
Departments of Dermatology, Otolaryngology, and Plastic Surgery, University of Pittsburgh, Pittsburgh, PA, USA
Search for more papers by this authorA.F. Haas
Sutter Health/Department of Dermatology, University of California-Davis, Sacramento, CA, USA
Search for more papers by this authorB.Y. Kang
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Search for more papers by this authorS.A. Ibrahim
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Search for more papers by this authorR.E. Christensen
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Search for more papers by this authorE. Poon
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Search for more papers by this authorB. Worley
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Florida Dermatology and Skin Cancer Centers, Lake Wales, FL, USA
Search for more papers by this author
Conflicts of interest
Dr. Etzkorn has received payments from Replimune for his participation on a data safety monitoring board or advisory board. The remaining authors have no conflicts of interest to disclose.
Open Research
Data Availability Statement
Data available upon reasonable request.
References
- 1Adamson AS, Zhou L, Baggett CD, Thomas NE, Meyer AM. Association of delays in surgery for melanoma with insurance type. JAMA Dermatol 2017; 153: 1106–1113.
- 2Lott JP, Narayan D, Soulos PR, Aminawung J, Gross CP. Delay of surgery for melanoma among medicare beneficiaries. JAMA Dermatol 2015; 151: 731–741.
- 3Niehues NB, Evanson B, Smith WA, Fiore CT, Parekh P. Melanoma patient notification and treatment timelines. Dermatol Online J 2019; 25:13030/qt0x15j2dk.
- 4Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2384 patients. Ophthalmology 2012; 119: 1582–1589.
- 5McKechnie AJ. See-and-treat surgery for facial skin cancer. Br J Oral Maxillofac Surg 2014; 52: 598–602.
- 6Wehner MR, Dalma N, Landefeld C et al. Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece. Br J Dermatol 2018; 179: 767–768.
- 7Alam M, Goldberg LH, Silapunt S et al. Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol 2011; 64: 839–848.
- 8Valenti M, Pavia G, Gargiulo L et al. Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospital. Int J Dermatol 2021; 60: 860–863
